Correlation Between Ascendis Pharma and VectivBio Holding

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ascendis Pharma and VectivBio Holding at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ascendis Pharma and VectivBio Holding into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ascendis Pharma AS and VectivBio Holding AG, you can compare the effects of market volatilities on Ascendis Pharma and VectivBio Holding and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ascendis Pharma with a short position of VectivBio Holding. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ascendis Pharma and VectivBio Holding.

Diversification Opportunities for Ascendis Pharma and VectivBio Holding

-0.43
  Correlation Coefficient

Very good diversification

The 3 months correlation between Ascendis and VectivBio is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Ascendis Pharma AS and VectivBio Holding AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on VectivBio Holding and Ascendis Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ascendis Pharma AS are associated (or correlated) with VectivBio Holding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of VectivBio Holding has no effect on the direction of Ascendis Pharma i.e., Ascendis Pharma and VectivBio Holding go up and down completely randomly.

Pair Corralation between Ascendis Pharma and VectivBio Holding

Given the investment horizon of 90 days Ascendis Pharma is expected to generate 8.92 times less return on investment than VectivBio Holding. But when comparing it to its historical volatility, Ascendis Pharma AS is 1.44 times less risky than VectivBio Holding. It trades about 0.03 of its potential returns per unit of risk. VectivBio Holding AG is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest  869.00  in VectivBio Holding AG on August 27, 2024 and sell it today you would earn a total of  816.00  from holding VectivBio Holding AG or generate 93.9% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy23.74%
ValuesDaily Returns

Ascendis Pharma AS  vs.  VectivBio Holding AG

 Performance 
       Timeline  
Ascendis Pharma AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ascendis Pharma AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Ascendis Pharma is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.
VectivBio Holding 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days VectivBio Holding AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, VectivBio Holding is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Ascendis Pharma and VectivBio Holding Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ascendis Pharma and VectivBio Holding

The main advantage of trading using opposite Ascendis Pharma and VectivBio Holding positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ascendis Pharma position performs unexpectedly, VectivBio Holding can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VectivBio Holding will offset losses from the drop in VectivBio Holding's long position.
The idea behind Ascendis Pharma AS and VectivBio Holding AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Other Complementary Tools

Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
CEOs Directory
Screen CEOs from public companies around the world
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Commodity Directory
Find actively traded commodities issued by global exchanges